Table 1.
Characteristic | Comment |
---|---|
Cytogenetics | Low incidence of: hyperdiploidy, t(12;21) High incidence of: hypodiploidy, t(9;22), other poor risk cytogenetics, IgH@ translocations, complex karyotype |
Molecular genetics | Increased frequency of mutations of: CRLF2, JAK, IKZF1, CDNK2A/B High incidence of: IAMP21, BCR-ABL-like |
Immunophenotype | Higher incidence of early T precursor ALL |
Response to chemotherapy | Higher MRD burden after induction chemotherapy |
Tolerabilty to intensive chemotherapy | Poorer in some studies |